• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Combined use of non-biological arti fi cial liver treatments for patients with acute liver failure complicated by multiple organ dysfunction syndrome

    2014-03-20 01:37:11
    World journal of emergency medicine 2014年3期

    Department of Intensive Care, Xuzhou Central Hospital, Affiliated to School of Medicine, Southeast University, Xuzhou 221009, China

    Corresponding Author:Mao-qin Li, Email: limaoqinxi@126.com

    Combined use of non-biological arti fi cial liver treatments for patients with acute liver failure complicated by multiple organ dysfunction syndrome

    Mao-qin Li, Jun-xiang Ti, Yun-hang Zhu, Zai-xiang Shi, Ji-yuan Xu, Bo Lu, Jia-qiong Li, Xiao-meng Wang, Yan-jun Xu

    Department of Intensive Care, Xuzhou Central Hospital, Affiliated to School of Medicine, Southeast University, Xuzhou 221009, China

    Corresponding Author:Mao-qin Li, Email: limaoqinxi@126.com

    BACKGROUND:Acute liver failure (ALF) caused by viral and non-viral hepatitis is often accompanied with severe metabolic disorders, the accumulation of toxic substances and continuous release and accumulation of a large number of endogenous toxins and inflammatory mediators. The present study aimed to investigate the effects of various combined non-biological arti fi cial liver treatments for patients with acute liver failure (ALF) complicated by multiple organ dysfunction syndrome (MODS).

    METHODS:Thirty-one patients with mid- or late-stage liver failure complicated by MODS (score 4) were randomly divided into three treatment groups: plasmapheresis (PE) combined with hemoperfusion (HP) and continuous venovenous hemodiafiltration (CVVHDF), PE+CVVHDF, and HP+CVVHDF, respectively. Heart rate (HR) before and after treatment, mean arterial pressure (MAP), respiratory index (PaO2/FiO2), hepatic function, platelet count, and blood coagulation were determined.

    RESULTS:Signi fi cant improvement was observed in HR, MAP, PaO2/FiO2, total bilirubin (TBIL) and alanine aminotransferase (ALT) levels after treatment (P<0.05). TBIL and ALT decreased more signi fi cantly after treatment in the PE+CVVHDF and PE+HP+CVVHDF groups (P<0.01). Prothrombin time (PT) and albumin were signi fi cantly improved only in the PE+CVVHDF and PE+HP+CVVHDF groups (P<0.05). TBIL decreased more significantly in the PE+HP+CVVHDF group than in the HP+CVVHDF and PE+CVVHDF groups (P<0.05). The survival rate of the patients was 58.1% (18/31), viral survival rate 36.4% (4/11), and non-viral survival rate 70% (14/20).

    CONCLUSION:Liver function was relatively improved after treatment, but PE+HP+CVVHDF was more efficient for the removal of toxic metabolites, especially bilirubin. The survival rate was signi fi cantly higher in the patients with non-viral liver failure than in those with viral liver failure.

    Severe acute liver failure; Artificial liver; Plasma exchange; Hemoperfusion; Continuous veno-venous hemodia fi ltration

    INTRODUCTION

    Acute liver failure (ALF) caused by viral and non-viral hepatitis is often accompanied with severe metabolic disorders, the accumulation of toxic substances and continuous release and accumulation of a large number of endogenous toxins and inflammatory mediators. In turn, this promotes liver damage and inhibits the regeneration of liver cells, creating a vicious cycle. Despite internal conventional therapies such as protecting liver function, improving jaundice, and a variety of medical support treatments, the clinical mortality of patients with severe ALF is still as high as 70%.[1]Artificial liver support system (ALSS) replaces liver function temporarily and partially, while removingall harmful substances and supplying biological active substances to create a good environment for regeneration and functional recovery of hepatic cells of the patient. Due to the limited effect of single ALSS, various combinations of non-biological artificial liver methods have become the hot topic. The present study aimed to observe the efficacy and safety of three combined ALSS regimens for the treatment of severe ALF: plasmapheresis (PE) combined with hemoperfusion (HP) and continuous venovenous hemodiafiltration (CVVHDF), PE+CVVHDF and HP+CVVHDF.

    METHODS

    General information

    Thirty-one patients with severe ALF were admitted to intensive care unit of Xuzhou Central Hospital from January 2007 to March 2013. The patients met the following criteria: liver score IV (total bilirubin>240 μmol/L) according to multiple organ dysfunction syndrome (MODS) score; and severe ALF complicated with MODS. In this series, 22 patients were male, and 9 were female, with a mean age of 38.1±14.8 years (range 20–82 years). Their chronic health evaluation II score (APACHE II) was 28.7±7.8, and sequential organ failure assessment score (SOFA score) was 13.67±3.31. Primary diseases in these patients included acute viral hepatitis (1 patient), ALF and chronic toxicity (10 patients), non-viral liver injury (cardiac surgery in 1 patient, poisoning in 6, pregnancy in 5, poisonous mushroom in 1, severe infection in 5, and others in 2). Liver failure staging[6]showed that all patients were in the stage of advanced liver failure with prothrombin activity (PTA)≤30%, including 23 patients with renal dysfunction, 15 patients with hepatic encephalopathy, 21 patients with gastrointestinal bleeding, 31 patients with blood clotting abnormalities, and 15 patients with circulatory dysfunction.

    The trial protocol was approved by the Ethics Committee of Xuezhou Central Hospital. All patients or their legal surrogates provided written informed consent for participation.

    Treatment

    In addition to conventional medicine and supportive treatment, the 31 patients were randomly treated with the following three regimens: PE+HP+CVVHDF, PE+CVVHDF or HP+CVVHDF.

    In the PE+HP +CVVHDF group, after establishing temporary access of the femoral vein or jugular vein catheterization, patients received plasmapheresis at bedside using a Swiss Campbell PF2000N plasma separator (permutation of fresh plasma 1 500–2 500 mL, plasma exchange fl ow rate 80–120 mL/min, plasma separation speed 25–30 mL/min, and replacement time 2–3 hours). After a single plasma exchange was completed, patients received HP, using neutral macroporous resin ( a HA330-II type hemoperfusion device produced by Zhuhai Franc). The hemoperfusion device was removed while its perfusion adsorption capacity for saturation and blood perfusion lasted 2–3 hours. Then, the patients were subjected to CVVHDF for (32.4±24.4) hours (range 10–49 hours).

    In the PE+CVVHDF group, patients underwent CVVHDF therapy after plasmapheresis. In the HP +CVVHDF group, patients underwent CVVHDF after HP.

    In the study, the 31 patients received a total of 81 treatments, including 23 treatments with PE+HP+CVVHDF, 26 treatments with PE+CVVHDF, and 32 treatments with HP+CVVHDF.

    Indicators

    The following indicators were observed: consciousness, heart rate (HR), mean arterial pressure (MAP), arterial blood gas (pH, PaO2, PaCO2), hepatic and renal function, blood count, electrolytes, and coagulation of each patient before and after treatment in the three groups.

    Statistical analysis

    Data of the three groups were expressed as the mean±SD. All analyses were performed using the SPSS 12.0 statistical package (SPSS Inc., Chicago, IL). Twoway ANOVA was used to compare the data between the three groups. All tests were two-tailed, and P values less than 0.05 were considered statistically signi fi cant.

    RESULTS

    General data

    There were no significant differences in age, SOFA score and treatment time between the three groups (P> 0.05) (Table 1).

    Table 1. Patients' age, SOFA score, and treatment time (mean ±SD)

    Table 2. HR, MAP, PaO2/FiO2and PLT before and after treatment (mean±SD)

    Table 3. Coagulation and liver function (mean ±SD)

    HR, MAP, PaO2/FiO2and platelets before and after treatment

    There were no significant differences in platelet changes before and after treatment in the three groups (P>0.05). HR, MAP and PaO2/FiO2increased more significantly after treatment than before treatment in the three groups (P<0.05). HR and PaO2/FiO2showed a significant change between the PE+HP+CVVHDF and HP+CVVHDF groups (P<0.05) (Table 2).

    Coagulation and liver function before and after treatment

    Total bilirubin (TBIL) and alanine aminotransferase (ALT) levels decreased more significantly after treatment than before treatment (P<0.05) in the PE+HP+ CVVHDF group and PE+CVVHDF group (P<0.01). However, TBIL decreased more significantly in the PE+HP+CVVHDF group than in the HP+CVVHDF and PE+CVVHDF groups. The changes of prothrombin time (PT) and albumin (ALB) level were statistically significant between the PE+HP+CVVHDF and PE+ CVVHDF groups (P<0.05) (Table 3).

    Clinical outcomes

    Of the 31 patients, 18 (58.1%) survived after treatment with the ALSS. In these patients, 4 were from the 11 patients with virus-caused liver failure, and 14 were from the 20 patients with non-virus-caused liver failure.

    DISCUSSION

    ALF is characterized by rapid onset, progression, and poor prognosis.[2]Actually, it is a kind of MODS. The treatment effect of simple conventional supportive care is not satisfactory, and blood purification technology can replace liver metabolic functions, thus supporting multiple organ function effectively.[3]The combined use of ALSS treatments plays a crucial role in decreasing the level of serum bilirubin, removing or reducing toxic substances, and improving the internal environment of ALF in liver failure patients. It has been reported that the survival rate of patients was 80%–90 % in the early course of ALF. Their interim survival rate was 60%–70%, while the survival rate of patients with advanced ALF was less than 20%.[4]Ye et al[5]reported that the survival rate was 48.3% for chronic severe hepatitis B patients treated with hemo fi ltration and plasmapheresis. He et al[6]reported that the survival rate was 45.5% for MODS patients with ALF in the ICU after treatment with pairing plasma separation adsorption and hemofiltration. The survival rate was 42.5% for MODS patients with ALF after treatment with plasma exchange and CVVHDF.[7]In our study, the liver function score was≥IV according to MODS score, and PTA was less than 30%. All patients were in the stage of advanced liver failure according to liver failure treatment guidelines.[8]We used three combined non-biological arti fi cial liver therapies, and 18 (58.1%) of the 31 patients survived. A significant improvement was observed in thesurvival rate compared to another study.[7]

    In our study, the survival rate of patients with nonvirus-caused liver failure was 70%, but the survival rate of patients with virus-caused liver failure was 36.4%. The finding suggested that the combined use of nonbiological artificial liver technology plays a significant role in improving the clinical outcomes. Different combinations of non-bioarti fi cial therapies were effective in improving severe metabolic disorders and removing accumulated toxic substances and inflammatory mediators caused by serious damage of liver cells. Thus, combined non-bioartificial therapies play a significant role in improving clinical outcomes. For patients with non-virus-caused severe ALF, combined ALSS plays a signi fi cant role in reducing the mortality.

    Three combined therapies with the non-biological arti fi cial liver revealed that there are signi fi cant differences in heart rate, mean arterial pressure, respiratory index after treatment compared with before treatment (P<0.05). TBIL and ALT in the PE+HP+CVVHDF group and PE+CVVHDF group decreased more significantly (P<0.01). PT and ALB changed significantly before and after treatment in the PE+HP+CVVHDF group and PE+CVVHDF group (P<0.05). The decrease of TBIL was more significant in the PE+HP+CVVHDF group than in the HP+CVVHDF and PE+CVVHDF groups. The results suggested that the combination of PE+HP+CVVHDF is more conducive to remove metabolites and scavenge poisons in addition to maintain homeostasis. PE can widely remove endogenous toxins (such as endotoxin, bilirubin, and bile acids) and macromolecules binding with plasma protein and circulating immune complexes.

    PE is not adequately effective because the small molecular weight toxins can easily pass through the blood vessel wall, and is widely distributed in tissues. HP can absorb aromatic amino acid, phenol, indole, shortchain fatty acids and others. Hemsoperfuion using HA resin perfusion, a neutral macroporous resin adsorption 500–5 000 Da major molecular weight substance, can absorb a variety of proteins binding toxins and cytotoxic substances, which inhibit regeneration of liver.[10]CVVH can continually eliminate the molecular substances, ammonia and other toxic substances such as false neurotransmitters, free fatty acids, amino acids, aromatic thiols in patients with acute liver failure, increase the content of CAMP in cerebrospinal fluid, improve energy metabolism in the brain, alleviate and ameliorate hepatic encephalopathy. CVVH can accurately control capacity, continuously and slowly remove the solute and liquid, regulate water, electrolyte and acid-base balance, and reduce the occurrence of brain edema in patients with acute liver failure.

    In conclusion, liver function was improved after three artificial liver treatments in the present study. PE+HP+CVVHDF was more effective to remove the metabolites and toxins, especially bilirubin. After treatment, the survival rate of patients with non-viruscaused liver failure was signi fi cantly higher than that of those with virus-caused liver failure.

    Funding:The study was supported by a grant from Xuzhou Municipal, China.

    Ethical approval:This study was approved by the ethical Committees of Xuzhou Central Hospital, Jiangsu Province, China.

    Con fl icts of interest:We have no con fl icts of interest to report.

    Contributors:Li MQ proposed the study and wrote the paper. All authors contributed to the design and interpretation of the study and to further drafts.

    REFERENCES

    1 Zheng Z, Li X, Li Z, Ma X. Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: A meta-analysis and meta-regression. Exp Ther Med 2013; 6: 929–936. Epub 2013 Jul 31.

    2 Majumdar M, Ratho R, Chawla Y, Singh MP. High levels of circulating HMGB1 as a biomarker of acute liver failure in patients with viral hepatitis E. Liver Int 2013; 33: 1341–1348.

    3 Song G, Li Y, Li M, Xuan R. Acute renal and liver failure due to acute fatty liver of pregnancy-complicated pre-eclampsia. J Obstet Gynaecol 2012; 32: 702–703.

    4 Takikawa Y, Suzuki K. Clinical epidemiology of fulminant hepatitis in Japan. Hepatol Res 2008; 38 Suppl 1: S14–18.

    5 Wu XL, Long D, Yu L, Yang JH, Zhang YC, Geng F. Urokinasetype plasminogen activator receptor as a predictor of poor outcome in patients with systemic infl ammatory response syndrome. World J Emerg Med 2013; 4: 190–195.

    6 Fang K, Wang XL. Treatment of multiple organ dysfunction syndrome by Xuebijing Injection: a clinical research. Zhongguo Zhong Xi Yi Jie He Za Zhi 2013; 33: 205–207.

    7 Li LJ, Zhang YM, Liu XL, Du WB, Huang JR, Yang Q, et al. Arti fi cial liver support system in China: a review over the last 30 years. Ther Apher Dial 2006; 10: 160–167.

    8 Chinese Society of Hepatology. Guidelines for liver failure. Chin J Hepatology 2006; 14: 543–646.

    9 Li MQ, Li JQ, Shi ZX, Xu JY, Zhang Z, Lu F, et al. Efficacy of various combined blood purification techniques for treating patients with non-viral acute liver failure. Cell Biochem Biophys 2014; 68: 571–575.

    10 Huang Z, Wang SR, Su W, Liu JY. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column. Ther Apher Dial 2010; 14: 596–602.

    Received January 11, 2014

    Accepted after revision July 3, 2014

    World J Emerg Med 2014;5(3):214–217

    10.5847/ wjem.j.issn.1920–8642.2014.03.010

    一个人免费在线观看电影| 人人妻人人澡欧美一区二区| 国产精品1区2区在线观看.| 国产又色又爽无遮挡免| 亚洲精品一区蜜桃| 久久久国产成人免费| 岛国在线免费视频观看| 精品午夜福利在线看| 精华霜和精华液先用哪个| 欧美一区二区精品小视频在线| 白带黄色成豆腐渣| 久久这里有精品视频免费| 免费黄网站久久成人精品| 青春草国产在线视频| 春色校园在线视频观看| 少妇猛男粗大的猛烈进出视频 | 成年av动漫网址| 国产亚洲av片在线观看秒播厂 | 中国国产av一级| 五月伊人婷婷丁香| av.在线天堂| 免费av不卡在线播放| 最近中文字幕2019免费版| 内射极品少妇av片p| 级片在线观看| 熟女人妻精品中文字幕| 午夜福利视频1000在线观看| 校园人妻丝袜中文字幕| 久久综合国产亚洲精品| 亚洲欧洲日产国产| 久久久久久久午夜电影| 少妇丰满av| 26uuu在线亚洲综合色| 少妇被粗大猛烈的视频| 欧美日韩在线观看h| 成人三级黄色视频| 男人舔奶头视频| 天天躁夜夜躁狠狠久久av| av福利片在线观看| 赤兔流量卡办理| 天堂av国产一区二区熟女人妻| 一级爰片在线观看| 精品久久久噜噜| 日韩视频在线欧美| 丝袜喷水一区| 中文字幕久久专区| 免费人成在线观看视频色| 欧美极品一区二区三区四区| 中文字幕精品亚洲无线码一区| 在现免费观看毛片| 插阴视频在线观看视频| 男女视频在线观看网站免费| 两个人视频免费观看高清| 午夜亚洲福利在线播放| 免费看美女性在线毛片视频| 国产成人福利小说| 少妇的逼好多水| 亚州av有码| 美女国产视频在线观看| 国产精品av视频在线免费观看| 黄片wwwwww| 国产一区二区三区av在线| 午夜日本视频在线| 国产精品国产三级专区第一集| 国内少妇人妻偷人精品xxx网站| 日本黄色视频三级网站网址| 亚洲国产高清在线一区二区三| 免费观看在线日韩| 亚洲成人av在线免费| 精品少妇黑人巨大在线播放 | 91aial.com中文字幕在线观看| 欧美日韩精品成人综合77777| 久久久久精品久久久久真实原创| 欧美日本亚洲视频在线播放| 亚洲成人精品中文字幕电影| 精品人妻视频免费看| 日韩欧美精品v在线| 国产精品无大码| 91aial.com中文字幕在线观看| 亚洲国产精品sss在线观看| 日日啪夜夜撸| av在线观看视频网站免费| 国内少妇人妻偷人精品xxx网站| 午夜福利在线在线| 欧美日韩在线观看h| 国产不卡一卡二| 久久久久久伊人网av| 最近最新中文字幕免费大全7| 免费不卡的大黄色大毛片视频在线观看 | 国产精品久久视频播放| 国产黄色小视频在线观看| 最近视频中文字幕2019在线8| 久久久久久国产a免费观看| 色哟哟·www| 床上黄色一级片| 长腿黑丝高跟| av又黄又爽大尺度在线免费看 | 一级毛片电影观看 | 欧美成人一区二区免费高清观看| 69人妻影院| 国产黄片视频在线免费观看| 欧美激情在线99| 国语对白做爰xxxⅹ性视频网站| 欧美成人a在线观看| 床上黄色一级片| 国产亚洲最大av| 最近视频中文字幕2019在线8| 日韩av在线大香蕉| 亚洲国产色片| 久久精品国产99精品国产亚洲性色| 久久久国产成人免费| 麻豆精品久久久久久蜜桃| 亚洲国产精品成人久久小说| 麻豆精品久久久久久蜜桃| 欧美成人免费av一区二区三区| 尤物成人国产欧美一区二区三区| 中文字幕人妻熟人妻熟丝袜美| 老师上课跳d突然被开到最大视频| av黄色大香蕉| 男女下面进入的视频免费午夜| 国产免费福利视频在线观看| 91午夜精品亚洲一区二区三区| 久久欧美精品欧美久久欧美| 亚洲精品日韩av片在线观看| 草草在线视频免费看| 26uuu在线亚洲综合色| 日韩欧美三级三区| 我要搜黄色片| 性插视频无遮挡在线免费观看| 2021少妇久久久久久久久久久| 久99久视频精品免费| 免费看日本二区| 一级爰片在线观看| 看黄色毛片网站| 九草在线视频观看| 国产高清不卡午夜福利| 国内少妇人妻偷人精品xxx网站| 日本五十路高清| 菩萨蛮人人尽说江南好唐韦庄 | 国产成人91sexporn| 国产黄a三级三级三级人| 日本av手机在线免费观看| 毛片女人毛片| 麻豆av噜噜一区二区三区| 天堂影院成人在线观看| 成人美女网站在线观看视频| 天天一区二区日本电影三级| 人体艺术视频欧美日本| 一区二区三区高清视频在线| 婷婷色综合大香蕉| 国产亚洲91精品色在线| 久久久精品欧美日韩精品| 亚洲高清免费不卡视频| 亚洲成人久久爱视频| 欧美高清性xxxxhd video| 亚洲在线观看片| 免费看光身美女| 永久网站在线| 免费看a级黄色片| 色吧在线观看| 少妇裸体淫交视频免费看高清| 欧美成人一区二区免费高清观看| 好男人在线观看高清免费视频| 久久精品国产99精品国产亚洲性色| 亚洲精品一区蜜桃| 91精品一卡2卡3卡4卡| 最近中文字幕2019免费版| 亚洲真实伦在线观看| 精品国产三级普通话版| 欧美精品国产亚洲| 少妇裸体淫交视频免费看高清| 美女内射精品一级片tv| 少妇人妻精品综合一区二区| 国产在视频线在精品| 一级毛片aaaaaa免费看小| 国产精品.久久久| 精品人妻偷拍中文字幕| 成人国产麻豆网| 中文字幕熟女人妻在线| 亚洲高清免费不卡视频| 国产精品国产三级国产专区5o | 成人毛片60女人毛片免费| 亚洲成人精品中文字幕电影| 亚洲国产欧美在线一区| 在线观看美女被高潮喷水网站| 毛片女人毛片| 亚洲国产成人一精品久久久| 午夜精品一区二区三区免费看| 国产精品乱码一区二三区的特点| 九九在线视频观看精品| 国产精品福利在线免费观看| 亚洲国产欧洲综合997久久,| 国国产精品蜜臀av免费| 久久6这里有精品| 国产精品一区www在线观看| 久久精品国产99精品国产亚洲性色| 日韩视频在线欧美| 人妻制服诱惑在线中文字幕| 成人毛片60女人毛片免费| 亚洲国产精品sss在线观看| 国产男人的电影天堂91| 色播亚洲综合网| 国模一区二区三区四区视频| 热99re8久久精品国产| 久久精品国产亚洲av天美| 免费一级毛片在线播放高清视频| 日韩,欧美,国产一区二区三区 | 欧美性猛交╳xxx乱大交人| 国产精华一区二区三区| 中文字幕亚洲精品专区| 秋霞伦理黄片| 网址你懂的国产日韩在线| 亚洲欧美精品专区久久| 久久久久久久午夜电影| 亚洲国产色片| 99热这里只有是精品50| 久久久久久久久久成人| 亚洲av日韩在线播放| 91av网一区二区| 九色成人免费人妻av| 久久午夜福利片| 桃色一区二区三区在线观看| 亚洲丝袜综合中文字幕| 亚洲成色77777| av国产免费在线观看| 嫩草影院精品99| 亚洲人与动物交配视频| 啦啦啦韩国在线观看视频| 在线观看66精品国产| 成人三级黄色视频| 淫秽高清视频在线观看| 天堂√8在线中文| 久久精品久久久久久噜噜老黄 | 青春草国产在线视频| 丝袜喷水一区| 看十八女毛片水多多多| 少妇人妻一区二区三区视频| 国产成人福利小说| 欧美xxxx黑人xx丫x性爽| 麻豆av噜噜一区二区三区| kizo精华| 91久久精品电影网| 成年女人永久免费观看视频| 一级av片app| 免费无遮挡裸体视频| 免费电影在线观看免费观看| 午夜精品在线福利| 一级毛片aaaaaa免费看小| 久久久久久九九精品二区国产| 色综合站精品国产| 国产人妻一区二区三区在| 黄色欧美视频在线观看| 国内精品美女久久久久久| 亚洲av成人av| 麻豆成人午夜福利视频| 看片在线看免费视频| 亚洲精品aⅴ在线观看| 黑人高潮一二区| 性色avwww在线观看| 久久精品国产亚洲av天美| 久久精品国产亚洲av涩爱| 日韩欧美精品v在线| 成人漫画全彩无遮挡| 午夜激情福利司机影院| 免费观看精品视频网站| 国内精品一区二区在线观看| 2022亚洲国产成人精品| 亚州av有码| 亚洲综合精品二区| 日本三级黄在线观看| 白带黄色成豆腐渣| 亚洲乱码一区二区免费版| 舔av片在线| 水蜜桃什么品种好| 国产精品麻豆人妻色哟哟久久 | 国产精品人妻久久久久久| 久久精品91蜜桃| 免费电影在线观看免费观看| 亚洲高清免费不卡视频| 高清毛片免费看| 久久鲁丝午夜福利片| 亚洲精品成人久久久久久| 国产亚洲最大av| 国产中年淑女户外野战色| 午夜免费男女啪啪视频观看| 九草在线视频观看| 日本五十路高清| 嫩草影院精品99| 最近的中文字幕免费完整| 可以在线观看毛片的网站| 亚洲精品aⅴ在线观看| 亚洲av成人av| 亚洲国产色片| 欧美潮喷喷水| ponron亚洲| 高清av免费在线| 亚洲国产精品成人久久小说| 99热精品在线国产| 国产乱人视频| 精品久久国产蜜桃| 99热全是精品| 中国美白少妇内射xxxbb| 一区二区三区高清视频在线| АⅤ资源中文在线天堂| 日本一二三区视频观看| 一级爰片在线观看| 我的老师免费观看完整版| 亚洲av免费在线观看| 18禁在线无遮挡免费观看视频| 中文字幕免费在线视频6| 日韩,欧美,国产一区二区三区 | 好男人视频免费观看在线| 国产精品久久电影中文字幕| 白带黄色成豆腐渣| 亚洲av成人精品一二三区| 好男人视频免费观看在线| 欧美成人午夜免费资源| 久久鲁丝午夜福利片| 少妇丰满av| 卡戴珊不雅视频在线播放| 九九爱精品视频在线观看| 欧美人与善性xxx| av国产免费在线观看| av在线播放精品| 亚洲国产精品国产精品| 精品熟女少妇av免费看| 亚洲一级一片aⅴ在线观看| 嫩草影院入口| 老师上课跳d突然被开到最大视频| 纵有疾风起免费观看全集完整版 | 国产极品精品免费视频能看的| 久久这里只有精品中国| 性色avwww在线观看| 成人美女网站在线观看视频| 我的老师免费观看完整版| 18禁在线播放成人免费| 老司机福利观看| 免费观看在线日韩| 免费不卡的大黄色大毛片视频在线观看 | 久久精品久久久久久噜噜老黄 | 久久这里有精品视频免费| 黄色配什么色好看| 成人国产麻豆网| 最近视频中文字幕2019在线8| 超碰97精品在线观看| 亚洲,欧美,日韩| 国产不卡一卡二| 春色校园在线视频观看| 欧美潮喷喷水| 亚洲精品久久久久久婷婷小说 | 99在线视频只有这里精品首页| 波多野结衣巨乳人妻| 日韩欧美精品v在线| 亚洲欧美清纯卡通| 国产精品熟女久久久久浪| 国产淫语在线视频| 国产极品天堂在线| 狠狠狠狠99中文字幕| 国产乱人偷精品视频| 国产午夜福利久久久久久| www.色视频.com| 亚洲精品国产av成人精品| 亚洲丝袜综合中文字幕| 亚洲精品日韩av片在线观看| 好男人视频免费观看在线| 欧美潮喷喷水| av在线观看视频网站免费| 91精品伊人久久大香线蕉| av在线老鸭窝| 91午夜精品亚洲一区二区三区| 视频中文字幕在线观看| 一卡2卡三卡四卡精品乱码亚洲| 女人久久www免费人成看片 | 少妇人妻精品综合一区二区| 伦精品一区二区三区| 久久久久久伊人网av| 国产淫片久久久久久久久| 97超碰精品成人国产| 亚洲国产精品sss在线观看| 成人无遮挡网站| 午夜精品一区二区三区免费看| 午夜福利在线在线| 六月丁香七月| 一级毛片aaaaaa免费看小| 国产午夜精品久久久久久一区二区三区| 深爱激情五月婷婷| 亚洲天堂国产精品一区在线| 神马国产精品三级电影在线观看| 观看美女的网站| 久久久久久久久久久丰满| 三级国产精品欧美在线观看| 乱人视频在线观看| 精品久久久久久成人av| 日本黄色视频三级网站网址| 国产视频首页在线观看| 中文字幕制服av| 国产免费一级a男人的天堂| 国产精品女同一区二区软件| videos熟女内射| 国产三级中文精品| 免费搜索国产男女视频| 大又大粗又爽又黄少妇毛片口| 亚洲欧美日韩无卡精品| 国语对白做爰xxxⅹ性视频网站| 免费av观看视频| 国产精品久久久久久精品电影| 国产人妻一区二区三区在| 日韩成人伦理影院| 26uuu在线亚洲综合色| 国产在视频线精品| 波多野结衣巨乳人妻| 男人舔女人下体高潮全视频| 最近手机中文字幕大全| 久久久久免费精品人妻一区二区| 亚洲怡红院男人天堂| 亚洲最大成人手机在线| 中文资源天堂在线| 亚洲美女视频黄频| 1024手机看黄色片| 麻豆成人av视频| 我的女老师完整版在线观看| 久久精品国产亚洲网站| 大香蕉久久网| 五月玫瑰六月丁香| 国产亚洲一区二区精品| 欧美最新免费一区二区三区| 国产精品爽爽va在线观看网站| 国产精品蜜桃在线观看| 身体一侧抽搐| 我要搜黄色片| 欧美一级a爱片免费观看看| 日本午夜av视频| 亚洲人与动物交配视频| 波野结衣二区三区在线| 久久综合国产亚洲精品| 十八禁国产超污无遮挡网站| 久久欧美精品欧美久久欧美| 亚洲五月天丁香| 联通29元200g的流量卡| 久久亚洲精品不卡| 晚上一个人看的免费电影| 亚洲精品日韩av片在线观看| 非洲黑人性xxxx精品又粗又长| 我的老师免费观看完整版| 一二三四中文在线观看免费高清| 91狼人影院| 偷拍熟女少妇极品色| 尾随美女入室| 一级毛片电影观看 | 免费看光身美女| 久久99热这里只有精品18| 日本黄色片子视频| 欧美日韩一区二区视频在线观看视频在线 | 免费电影在线观看免费观看| 免费看av在线观看网站| 亚洲第一区二区三区不卡| 久久99热这里只频精品6学生 | 你懂的网址亚洲精品在线观看 | 国产成人一区二区在线| 亚洲熟妇中文字幕五十中出| 精品久久久久久久久久久久久| 一级毛片aaaaaa免费看小| 高清视频免费观看一区二区 | av国产免费在线观看| 亚洲人与动物交配视频| 在线天堂最新版资源| 成人漫画全彩无遮挡| 大又大粗又爽又黄少妇毛片口| 亚洲av成人精品一二三区| 99热6这里只有精品| 成年版毛片免费区| 嫩草影院精品99| 啦啦啦观看免费观看视频高清| 国内揄拍国产精品人妻在线| 啦啦啦啦在线视频资源| 久久精品人妻少妇| 国产精华一区二区三区| 日韩,欧美,国产一区二区三区 | 亚洲av成人精品一区久久| 色综合亚洲欧美另类图片| 一级av片app| 国产三级中文精品| 久久久久网色| 亚洲中文字幕一区二区三区有码在线看| 99久久无色码亚洲精品果冻| 欧美日韩国产亚洲二区| 久久久久久国产a免费观看| 国产综合懂色| 久久亚洲精品不卡| 国产精品国产三级国产专区5o | 美女黄网站色视频| 久久久久久久国产电影| 村上凉子中文字幕在线| 精品人妻熟女av久视频| 国产极品精品免费视频能看的| 嫩草影院入口| 在线播放无遮挡| 国产精品一区二区三区四区久久| 亚洲国产精品国产精品| 少妇丰满av| 美女高潮的动态| 神马国产精品三级电影在线观看| 成人av在线播放网站| 国产av码专区亚洲av| 91久久精品国产一区二区成人| 国产精品不卡视频一区二区| 国产国拍精品亚洲av在线观看| av黄色大香蕉| 九九久久精品国产亚洲av麻豆| 国产精品久久久久久久久免| 久久99精品国语久久久| 久久精品夜色国产| 欧美又色又爽又黄视频| 韩国高清视频一区二区三区| 欧美日本亚洲视频在线播放| 韩国av在线不卡| 91久久精品电影网| 亚洲精品国产av成人精品| 精品酒店卫生间| 视频中文字幕在线观看| 欧美日本视频| 国产av不卡久久| 精品人妻一区二区三区麻豆| 99久久精品热视频| 亚洲精品乱码久久久v下载方式| 黄片wwwwww| 国产视频内射| 久久欧美精品欧美久久欧美| 国产精品美女特级片免费视频播放器| 寂寞人妻少妇视频99o| 大香蕉97超碰在线| 在线a可以看的网站| 亚洲五月天丁香| 三级经典国产精品| 久久精品久久精品一区二区三区| 国产伦理片在线播放av一区| 激情 狠狠 欧美| 在线播放无遮挡| 欧美性猛交黑人性爽| 国产伦精品一区二区三区四那| 亚洲国产欧美人成| 成人午夜精彩视频在线观看| 亚洲欧洲日产国产| 国产色婷婷99| 久久人人爽人人爽人人片va| 啦啦啦观看免费观看视频高清| 亚洲熟妇中文字幕五十中出| 亚洲在线自拍视频| 日韩大片免费观看网站 | 国产亚洲精品av在线| 狂野欧美激情性xxxx在线观看| 人人妻人人看人人澡| 97在线视频观看| 成人一区二区视频在线观看| 国产成人精品婷婷| 午夜精品一区二区三区免费看| 亚洲18禁久久av| 久久久久久久亚洲中文字幕| 久久久久久久久大av| 国产亚洲av片在线观看秒播厂 | 高清午夜精品一区二区三区| 国语对白做爰xxxⅹ性视频网站| 色网站视频免费| 午夜老司机福利剧场| 精品国产一区二区三区久久久樱花 | 99久久九九国产精品国产免费| 女人十人毛片免费观看3o分钟| 久久久久国产网址| 一二三四中文在线观看免费高清| h日本视频在线播放| av国产久精品久网站免费入址| 三级男女做爰猛烈吃奶摸视频| 97热精品久久久久久| av福利片在线观看| 亚洲精品影视一区二区三区av| 免费无遮挡裸体视频| 国模一区二区三区四区视频| 日本免费在线观看一区| 国产片特级美女逼逼视频| 我的老师免费观看完整版| 熟女人妻精品中文字幕| 久久久午夜欧美精品| 建设人人有责人人尽责人人享有的 | 欧美丝袜亚洲另类| 亚洲av中文av极速乱| 麻豆乱淫一区二区| 日韩欧美精品v在线| 特大巨黑吊av在线直播| 热99在线观看视频| 国产 一区 欧美 日韩| 久久人人爽人人爽人人片va| 国产午夜精品一二区理论片| 一级二级三级毛片免费看| 国产精品乱码一区二三区的特点| 少妇猛男粗大的猛烈进出视频 | 欧美成人一区二区免费高清观看| 波野结衣二区三区在线| 18禁裸乳无遮挡免费网站照片| 大话2 男鬼变身卡| 亚洲欧美一区二区三区国产| 2021天堂中文幕一二区在线观| 精品无人区乱码1区二区| 国产一区二区三区av在线| 亚洲久久久久久中文字幕| 我的女老师完整版在线观看| 免费观看精品视频网站| 男女国产视频网站| 高清视频免费观看一区二区 | 日本av手机在线免费观看| 免费无遮挡裸体视频| 久久久久九九精品影院| 两个人的视频大全免费| 免费黄色在线免费观看| 村上凉子中文字幕在线| 欧美另类亚洲清纯唯美|